Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals

F. Errico, R. Nisticò, A. Di Giorgio, M. Squillace, D. Vitucci, A. Galbusera, S. Piccinin, D. Mango, L. Fazio, S. Middei, S. Trizio, N. B. Mercuri, M. A. Teule, D. Centonze, A. Gozzi, G. Blasi, A. Bertolino, A. Usiello

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

D-aspartate (D-Asp) is an atypical amino acid, which is especially abundant in the developing mammalian brain, and can bind to and activate N-methyl-D-Aspartate receptors (NMDARs). In line with its pharmacological features, we find that mice chronically treated with D-Asp show enhanced NMDAR-mediated miniature excitatory postsynaptic currents and basal cerebral blood volume in fronto-hippocampal areas. In addition, we show that both chronic administration of D-Asp and deletion of the gene coding for the catabolic enzyme D-aspartate oxidase (DDO) trigger plastic modifications of neuronal cytoarchitecture in the prefrontal cortex and CA1 subfield of the hippocampus and promote a cytochalasin D-sensitive form of synaptic plasticity in adult mouse brains. To translate these findings in humans and consistent with the experiments using Ddo gene targeting in animals, we performed a hierarchical stepwise translational genetic approach. Specifically, we investigated the association of variation in the gene coding for DDO with complex human prefrontal phenotypes. We demonstrate that genetic variation predicting reduced expression of DDO in postmortem human prefrontal cortex is mapped on greater prefrontal gray matter and activity during working memory as measured with MRI. In conclusion our results identify novel NMDAR-dependent effects of D-Asp on plasticity and physiology in rodents, which also map to prefrontal phenotypes in humans.

Original languageEnglish
Article numbere417
JournalTranslational Psychiatry
Volume4
DOIs
Publication statusPublished - Jul 29 2014

Fingerprint

D-Aspartic Acid
Neuronal Plasticity
Mammals
N-Methyl-D-Aspartate Receptors
Brain
Prefrontal Cortex
D-Aspartate Oxidase
Phenotype
Cytochalasin D
Gene Targeting
Excitatory Postsynaptic Potentials
Gene Deletion
Short-Term Memory
Plastics
Rodentia
Hippocampus
Pharmacology
Amino Acids
Gray Matter
Enzymes

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Cellular and Molecular Neuroscience

Cite this

Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. / Errico, F.; Nisticò, R.; Di Giorgio, A.; Squillace, M.; Vitucci, D.; Galbusera, A.; Piccinin, S.; Mango, D.; Fazio, L.; Middei, S.; Trizio, S.; Mercuri, N. B.; Teule, M. A.; Centonze, D.; Gozzi, A.; Blasi, G.; Bertolino, A.; Usiello, A.

In: Translational Psychiatry, Vol. 4, e417, 29.07.2014.

Research output: Contribution to journalArticle

Errico, F, Nisticò, R, Di Giorgio, A, Squillace, M, Vitucci, D, Galbusera, A, Piccinin, S, Mango, D, Fazio, L, Middei, S, Trizio, S, Mercuri, NB, Teule, MA, Centonze, D, Gozzi, A, Blasi, G, Bertolino, A & Usiello, A 2014, 'Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals', Translational Psychiatry, vol. 4, e417. https://doi.org/10.1038/tp.2014.59
Errico, F. ; Nisticò, R. ; Di Giorgio, A. ; Squillace, M. ; Vitucci, D. ; Galbusera, A. ; Piccinin, S. ; Mango, D. ; Fazio, L. ; Middei, S. ; Trizio, S. ; Mercuri, N. B. ; Teule, M. A. ; Centonze, D. ; Gozzi, A. ; Blasi, G. ; Bertolino, A. ; Usiello, A. / Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. In: Translational Psychiatry. 2014 ; Vol. 4.
@article{4da77b30adf34cf897cbd421350041c8,
title = "Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals",
abstract = "D-aspartate (D-Asp) is an atypical amino acid, which is especially abundant in the developing mammalian brain, and can bind to and activate N-methyl-D-Aspartate receptors (NMDARs). In line with its pharmacological features, we find that mice chronically treated with D-Asp show enhanced NMDAR-mediated miniature excitatory postsynaptic currents and basal cerebral blood volume in fronto-hippocampal areas. In addition, we show that both chronic administration of D-Asp and deletion of the gene coding for the catabolic enzyme D-aspartate oxidase (DDO) trigger plastic modifications of neuronal cytoarchitecture in the prefrontal cortex and CA1 subfield of the hippocampus and promote a cytochalasin D-sensitive form of synaptic plasticity in adult mouse brains. To translate these findings in humans and consistent with the experiments using Ddo gene targeting in animals, we performed a hierarchical stepwise translational genetic approach. Specifically, we investigated the association of variation in the gene coding for DDO with complex human prefrontal phenotypes. We demonstrate that genetic variation predicting reduced expression of DDO in postmortem human prefrontal cortex is mapped on greater prefrontal gray matter and activity during working memory as measured with MRI. In conclusion our results identify novel NMDAR-dependent effects of D-Asp on plasticity and physiology in rodents, which also map to prefrontal phenotypes in humans.",
author = "F. Errico and R. Nistic{\`o} and {Di Giorgio}, A. and M. Squillace and D. Vitucci and A. Galbusera and S. Piccinin and D. Mango and L. Fazio and S. Middei and S. Trizio and Mercuri, {N. B.} and Teule, {M. A.} and D. Centonze and A. Gozzi and G. Blasi and A. Bertolino and A. Usiello",
year = "2014",
month = "7",
day = "29",
doi = "10.1038/tp.2014.59",
language = "English",
volume = "4",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals

AU - Errico, F.

AU - Nisticò, R.

AU - Di Giorgio, A.

AU - Squillace, M.

AU - Vitucci, D.

AU - Galbusera, A.

AU - Piccinin, S.

AU - Mango, D.

AU - Fazio, L.

AU - Middei, S.

AU - Trizio, S.

AU - Mercuri, N. B.

AU - Teule, M. A.

AU - Centonze, D.

AU - Gozzi, A.

AU - Blasi, G.

AU - Bertolino, A.

AU - Usiello, A.

PY - 2014/7/29

Y1 - 2014/7/29

N2 - D-aspartate (D-Asp) is an atypical amino acid, which is especially abundant in the developing mammalian brain, and can bind to and activate N-methyl-D-Aspartate receptors (NMDARs). In line with its pharmacological features, we find that mice chronically treated with D-Asp show enhanced NMDAR-mediated miniature excitatory postsynaptic currents and basal cerebral blood volume in fronto-hippocampal areas. In addition, we show that both chronic administration of D-Asp and deletion of the gene coding for the catabolic enzyme D-aspartate oxidase (DDO) trigger plastic modifications of neuronal cytoarchitecture in the prefrontal cortex and CA1 subfield of the hippocampus and promote a cytochalasin D-sensitive form of synaptic plasticity in adult mouse brains. To translate these findings in humans and consistent with the experiments using Ddo gene targeting in animals, we performed a hierarchical stepwise translational genetic approach. Specifically, we investigated the association of variation in the gene coding for DDO with complex human prefrontal phenotypes. We demonstrate that genetic variation predicting reduced expression of DDO in postmortem human prefrontal cortex is mapped on greater prefrontal gray matter and activity during working memory as measured with MRI. In conclusion our results identify novel NMDAR-dependent effects of D-Asp on plasticity and physiology in rodents, which also map to prefrontal phenotypes in humans.

AB - D-aspartate (D-Asp) is an atypical amino acid, which is especially abundant in the developing mammalian brain, and can bind to and activate N-methyl-D-Aspartate receptors (NMDARs). In line with its pharmacological features, we find that mice chronically treated with D-Asp show enhanced NMDAR-mediated miniature excitatory postsynaptic currents and basal cerebral blood volume in fronto-hippocampal areas. In addition, we show that both chronic administration of D-Asp and deletion of the gene coding for the catabolic enzyme D-aspartate oxidase (DDO) trigger plastic modifications of neuronal cytoarchitecture in the prefrontal cortex and CA1 subfield of the hippocampus and promote a cytochalasin D-sensitive form of synaptic plasticity in adult mouse brains. To translate these findings in humans and consistent with the experiments using Ddo gene targeting in animals, we performed a hierarchical stepwise translational genetic approach. Specifically, we investigated the association of variation in the gene coding for DDO with complex human prefrontal phenotypes. We demonstrate that genetic variation predicting reduced expression of DDO in postmortem human prefrontal cortex is mapped on greater prefrontal gray matter and activity during working memory as measured with MRI. In conclusion our results identify novel NMDAR-dependent effects of D-Asp on plasticity and physiology in rodents, which also map to prefrontal phenotypes in humans.

UR - http://www.scopus.com/inward/record.url?scp=84905239138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905239138&partnerID=8YFLogxK

U2 - 10.1038/tp.2014.59

DO - 10.1038/tp.2014.59

M3 - Article

VL - 4

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

M1 - e417

ER -